1. Sarvari J, Mojtahedi Z, Kuramitsu Y, Fattahi MR, Ghaderi A, Nakamura K, Erfani N (2014) Comparative proteomics of sera from HCC patients with different origins. Hepatitis Monthly. https://doi.org/10.5812/hepatmon.13103
2. Ghouri A, Kumar S, Khan SA, Ghani MH, Aslam S, Asadullah (2014) Frequency of type 2 diabetes mellitus in patients with chronic hepatitis C virus infection. J Liaquat Uni Med Health Sci 13:51–56
3. Dehghani B, Dehghani A, Sarvari J (2019) Knowledge and awareness regarding hepatitis B, hepatitis C, and human immunodeficiency viruses among college students: a report from Iran. Int Quart Commun Health Educ. https://doi.org/10.1177/0272684X19896727
4. Ajorloo M, Bamdad T, Hashempour T, Alborzi AM, Mozhgani SHR, Asadi R, Haj SA, Merat S (2015) Detection of specific antibodies to HCV-ARF/CORE+ 1 protein in cirrhotic and non-cirrhotic patients with hepatitis C: a possible association with progressive fibrosis. Arch Iran Med 18:304–307
5. Hashempoor T, Bamdad T, Merat S, Janzamin E, Nemati L, Jabbari H, Sharifi A-H, Zamini H (2010) Expansion of CD4 + CD25 + FoxP3 + regulatory T cells in chronic hepatitis C virus infection. Iran J Immunol 7(3):177–185